Topic

Blood cells Steady

383 applications whose title mentions it. Its share of new filings over the last two years is -18% below the four years before.

Allowance rate

62%

−13 pts vs the USPTO 334 decided

Months to first action

19.7 mo

+1.1 vs the USPTO

Applications

383.0

in the record

Allowed

207.0

127 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

G01N116 apps

A61K67 apps

C12N48 apps

A01N42 apps

A61M37 apps

C12Q15 apps

Art units

165738 apps

165126 apps

163222 apps

165321 apps

163320 apps

177719 apps

Examiners

Who examines it, and how it fares with each

Docket Central17 apps

n/a

Gailene Gabel16 apps

44%

Sandra E Saucier12 apps

50%

Ralph J Gitomer11 apps

82%

Teresa E Knight10 apps

90%

Dean P Kwak10 apps

80%

Neil N Turk8 apps

38%

Sun U Kim7 apps

86%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

Fenwal, Inc.24 apps

96%

ABBOTT LABORATORIES12 apps

83%

Abbott Point of Care Inc.10 apps

70%

Hemanext Inc.10 apps

100%

Biomet Biologics, LLC8 apps

88%

KELLBENX INCORPORATED7 apps

17%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

COOK ALEX LTD./FENWAL, INC.24 apps

96%

Arnold & Porter Kaye Scholer LLP15 apps

100%

Abbott Laboratories (ADDV)13 apps

69%

WOLF GREENFIELD & SACKS, P.C.10 apps

70%

Schwegman Lundberg & Woessner / Zimmer8 apps

88%

BALLARD SPAHR LLP6 apps

80%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19615035	USE OF VDAC AND LAMP1 AS MARKERS FOR DETECTING POCKED RED BLOOD CELLS	2026-08-13	Pending	0	0	n/a
19612724	EPISOMAL REPROGRAMMING OF ISOLATED CELL FRACTION FROM CORD BLOOD UNITS AND GENERATI…	2026-08-05	Pending	0	0	n/a
19611467	ENGINEERED NANOPARTICLES FOR TARGETED INTERNALIZATION BY HUMAN BLOOD CELLS	2026-07-31	Pending	0	0	n/a
15932797	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15808757	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15891579	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15863172	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15140514	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15912288	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15302847	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in